Commentary on "Cannabinoids for Agitation in Alzheimer's Disease". Am J Geriatr Psychiatry 2021 Dec;29(12):1264-1266
Date
04/12/2021Pubmed ID
33839012Pubmed Central ID
PMC8449786DOI
10.1016/j.jagp.2021.03.004Scopus ID
2-s2.0-85103976184 (requires institutional sign-in at Scopus site)Author List
Goveas JSAuthor
Joseph S. Goveas MD Professor in the Psychiatry and Behavioral Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Alzheimer DiseaseAnxiety
Cannabinoids
Humans
Psychomotor Agitation
